Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)

Clinical trial NCT06079671 · RECRUITING

Trial details

NCT number: NCT06079671
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Locally Advanced Cervical Cancer

Start date: 2023-09-22
Primary completion: 2027-11-26
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.